05/02/2024
5:01 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:19 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
5:33 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:33 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:33 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:10 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/12/2024
4:12 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/11/2024
3:06 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/10/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
6:06 AM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
12:17 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
6:01 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/27/2024
6:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/11/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
6:20 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:22 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:51 PM | Nurix Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
6:22 AM | Nurix Therapeutics (Issuer)
SANDS ARTHUR T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:51 AM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:00 AM | Nurix Therapeutics (Subject)
SANDS ARTHUR T (Filed by)
| Form SC 13G | |
02/09/2024
12:47 PM | MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G | |
02/09/2024
12:56 PM | Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
01/30/2024
5:52 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:52 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:53 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024
9:28 AM | Nurix Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024
6:03 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:19 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:55 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
11:03 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
3:40 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
3:40 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
3:41 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:03 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (Ad) As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely! Learn how this American company is leading the lithium-ion revolution |
10/12/2023
3:06 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/07/2023
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
3:26 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
3:27 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
3:28 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
3:18 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:19 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
